Upper Airway Stimulation Therapy

UAS Fundamentals - Nerve Zapper Intro

• Upper Airway Stimulation (UAS): Implantable neurostimulation device for treating Obstructive Sleep Apnea (OSA).
• Indication: For moderate to severe OSA patients who are intolerant or non-adherent to CPAP therapy.
• Mechanism: Delivers mild electrical stimulation to the hypoglossal nerve (CN XII) during sleep.
  • Stimulation is synchronized with the patient's breathing.
  • Prevents airway collapse, especially at the tongue base.
• Components:
  • Implantable pulse generator (IPG) - usually placed in the chest.
  • Sensing lead - detects respiratory effort.
  • Stimulation lead - activates genioglossus muscle for tongue movement.
• Goal: Improve airway patency by stiffening and protruding the tongue.

  ⭐ UAS primarily targets the genioglossus muscle via hypoglossal nerve stimulation.

• "Nerve Zapper": Colloquial term describing its electrical action on the nerve.

Patient Selection - The "Who's Who"

Key to successful Upper Airway Stimulation (UAS) is meticulous patient selection.

• Inclusion Criteria:
  • Age: ≥18 years
  • Moderate to Severe OSA: AHI 15-65/hr, predominantly obstructive
  • BMI: <32-35 kg/m² (device-specific, e.g., Inspire uses <32)
  • CPAP failure or intolerance (documented)
  • Patient motivation & realistic expectations
• Exclusion Criteria (Key):
  • Anatomical:
    • Complete Concentric Collapse (CCC) of soft palate on DISE
  • Physiological:
    • Significant central sleep apnea (>25% of events)
    • Hypoventilation syndromes
  • BMI > 32-35 kg/m²
  • Certain neuromuscular diseases

⭐ Drug-Induced Sleep Endoscopy (DISE) is mandatory to exclude complete concentric collapse (CCC) at the velopharynx, a key contraindication.

The Device & Procedure - Implant Insights

• UAS System Components:
  • Implantable Pulse Generator (IPG): Placed in a subcutaneous chest wall pocket.
  • Stimulation Lead: Cuff electrode on hypoglossal nerve (HGN XII), specifically targeting branches innervating the genioglossus muscle (tongue protrusor).
  • Respiratory Sensing Lead: Placed between intercostal muscles; detects respiratory effort to synchronize stimulation.
• Surgical Implantation:
  • Procedure performed under general anesthesia.
  • Typically involves two to three incisions: submandibular (for HGN lead), infraclavicular (for IPG), and lateral thoracic (for sensing lead).
  • Intraoperative nerve integrity monitoring is essential.
• Activation & Titration:
  • Device typically activated ~1 month post-operatively to allow for healing.
  • Optimal stimulation settings are determined via a titration study in a sleep laboratory.

⭐ The UAS system consists of three main components: a stimulation electrode cuff on the hypoglossal nerve, a respiratory sensing lead, and an implantable pulse generator (IPG).

Outcomes & Hurdles - Zapping Success?

• Positive Outcomes:
  • ↓ AHI (Apnea-Hypopnea Index).
  • ↓ ODI (Oxygen Desaturation Index).
  • ↓ ESS (Epworth Sleepiness Scale) scores.
  • ↑ QoL (Quality of Life).
  • Snoring reduction.
  • Sustained long-term efficacy in responders.
• Defining Success:

  ⭐ Successful UAS therapy is often defined by a >50% reduction in AHI to <20/hr and significant improvement in ODI and subjective sleepiness (ESS).

• Potential Hurdles & Complications:
  • Strict patient selection: BMI <32-35 kg/m², AHI 15-65/hr, specific collapse patterns (no CCC at velum).
  • Surgical risks: Hypoglossal nerve (CN XII) injury (transient/rare), infection, pain.
  • Device-related: Discomfort, lead issues (fracture/migration), battery depletion.
  • Titration period post-implantation.
  • Cost.
  • Tongue stimulation awareness.

High‑Yield Points - ⚡ Biggest Takeaways

• UAS treats OSA via hypoglossal nerve (CN XII) stimulation, improving airway patency.
• Synchronous tongue protrusion with inspiration relieves retrolingual obstruction.
• For moderate-severe OSA (AHI 15-65), BMI <32-35 kg/m², with CPAP failure/intolerance.
• DISE is essential to exclude Complete Concentric Collapse (CCC) at the palate.
• Significantly reduces AHI and Oxygen Desaturation Index (ODI), improving sleep quality.
• Implantable system: pulse generator, sensing lead (intercostal), and CN XII stimulation cuff_._